Deep Track Capital’s Obsidian Therapeutics OBX Stock Holding History
Bought
Maintained
Sold
Other funds holding OBX
Deep Track Capital's OBX Position: Q3 2026 in Review
Deep Track Capital opened a new position in Obsidian Therapeutics (OBX) in Q3 2026: 2,120,050 shares worth $29.1M. The stake represents 0.47% of the portfolio and ranks #48 among its holdings.
60 funds tracked by Wall St. Rank hold OBX as of Q3 2026.
- Deep Track Capital held 2,120,050 shares of Obsidian Therapeutics worth $29.1M as of Q3 2026.
- Obsidian Therapeutics was a new Deep Track Capital position in Q3 2026.
- Obsidian Therapeutics made up 0.47% of Deep Track Capital's portfolio in Q3 2026, its #48 holding.
- 60 funds tracked by Wall St. Rank held Obsidian Therapeutics as of Q3 2026.
Based on Deep Track Capital's 13F filing for Q3 2026, filed 16 Nov 2026.